MAIORCA, Rosario
 Distribuzione geografica
Continente #
NA - Nord America 6.573
EU - Europa 4.088
AS - Asia 2.733
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 12
AF - Africa 8
SA - Sud America 8
Totale 13.435
Nazione #
US - Stati Uniti d'America 6.538
UA - Ucraina 1.899
CN - Cina 1.406
DE - Germania 614
SG - Singapore 591
HK - Hong Kong 416
IT - Italia 413
FI - Finlandia 364
IE - Irlanda 230
TR - Turchia 218
RU - Federazione Russa 197
GB - Regno Unito 129
FR - Francia 110
IN - India 69
SE - Svezia 50
CA - Canada 30
IR - Iran 19
BE - Belgio 18
AU - Australia 13
NL - Olanda 13
EU - Europa 12
CZ - Repubblica Ceca 8
PL - Polonia 6
LV - Lettonia 5
RO - Romania 5
GR - Grecia 4
MX - Messico 4
PE - Perù 4
AT - Austria 3
CH - Svizzera 3
HR - Croazia 3
AM - Armenia 2
BG - Bulgaria 2
ES - Italia 2
HU - Ungheria 2
KR - Corea 2
LU - Lussemburgo 2
MA - Marocco 2
MU - Mauritius 2
SA - Arabia Saudita 2
AR - Argentina 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BO - Bolivia 1
BR - Brasile 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
GH - Ghana 1
ID - Indonesia 1
IL - Israele 1
JP - Giappone 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
NG - Nigeria 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 13.435
Città #
Jacksonville 1.166
Woodbridge 816
Fairfield 654
Singapore 470
Princeton 466
Houston 426
Hong Kong 413
Ann Arbor 402
Nanjing 398
Cambridge 346
Chandler 336
Ashburn 307
Wilmington 282
Dublin 229
Seattle 224
Istanbul 199
Nanchang 153
Beijing 143
Helsinki 130
Des Moines 110
Shenyang 105
Hebei 83
New York 83
Milan 80
Moscow 72
Tianjin 69
Changsha 67
Jiaxing 66
Dearborn 64
Jinan 56
San Diego 44
Hangzhou 42
Verona 41
Kunming 36
Lanzhou 28
San Mateo 28
Ningbo 27
Toronto 26
Shanghai 25
Norwalk 21
Munich 19
Monmouth Junction 18
Rome 18
Ardabil 16
Kocaeli 15
Leawood 15
Zhengzhou 15
Brussels 14
San Francisco 14
Taizhou 14
Haikou 11
Augusta 9
Guangzhou 9
Taiyuan 9
Washington 9
Brno 7
Changchun 7
Santa Clara 7
Catania 6
Menlo Park 6
Orange 6
Canberra 5
Edinburgh 5
Hefei 5
Melbourne 5
Athens 4
Carbonia 4
Cosenza 4
Lancaster 4
Palermo 4
Venezia 4
Bangalore 3
Brescia 3
Cardano al Campo 3
Fuzhou 3
Hanover 3
Lima 3
London 3
Redwood City 3
Riga 3
Torino 3
Vienna 3
Azzano San Paolo 2
Baotou 2
Bari 2
Bologna 2
Casarano 2
Caserta 2
Central 2
Chiswick 2
Cremona 2
Ercolano 2
Icheon-si 2
Illingen 2
Inwood 2
Jesi 2
Kilburn 2
Lanuvio 2
Livorno 2
Los Angeles 2
Totale 9.090
Nome #
A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation. 127
Acute visual disorders in patients on regular dialysis given desferrioxamine as a test 123
A controlled trial of two bicarbonate-containing dialysis fluids for CAPD--final report. 119
A large TSC2 and PKD1 gene deletion is associated with renal and extrarenal signs of autosomal dominant polycystic kidney disease 115
Effects of changes in intravascular volume on atrial size and plasma levels of immunoreactive atrial natriuretic peptide in uremic man 113
Assessment of calcemic status in dialyzed uraemic patients. 113
A six year comparison of patient and technique survivals in CAPD and HD 109
La sindrome oro-facio-digitale tipo 1: una causa infrequente di malattia cistica renale a carattere ereditario. 109
Viral hepatitis in HBsAg-positive renal transplant patients treated with cyclosporin and steroids. 108
Which vascular access for chronic hemodialysis in uremic elderly patients? 107
Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients: a longitudinal study. 107
Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients 106
A randomized controlled trial of a bicarbonate - and a bicarbonate/lactate - containing dialysis solution in CAPD 103
Inter-dialytic variations in blood volume and total body water in uraemic patients treated by dialysis. 103
Liver disease in renal transplant patients treated with azathioprine or ciclosporin. 102
Antiphospholipid syndrome and glomerular thrombosis in the absence of overt lupus nephritis 100
Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. 99
Von Hippel-Lindau syndrome presenting as pancreatic cysts 98
Viral infection in kidney-transplanted patients. 97
Interrelationships between blood pressure, blood gases and plasma acetate concentrations during conventional hemodialysis. 96
Oral-facial-digital syndrome type I: an unusual cause of hereditary cystic kidney disease 96
Plasma catecholamine response to postural stimulation in normotensive and dialysis hypotension-prone uremic patients. 94
Sarcoma di Kaposi (SK) in corso di trapianto renale. Esperienza clinica in 7 casi. 94
Two different types of renal involvement in tuberous sclerosis complex. 93
Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study 93
Iperplasia gengivale indotta da ciclosporina: aspetti clinici e istologici. 92
Oral-facial-digital syndrome type 1 coexisting with polycystic kidney disease. 91
Anemia emolitica autoimmune acquisita (AEAA) da incompatibilità minore ABO: un raro esempio di graft versus host disease (GVHD) in corso di trapianto di rene (TX). 91
Cholesterol atheromatous embolism: an increasingly recognized cause of acute renal failure. 90
Medullary cystic kidney disease: past and present. 89
Evidence for an independent role of metabolic acidosis on nutritional status in haemodialysis patients. 88
Kidney transplantation in Alport's syndrome. 88
Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. 88
PD or not PD? That is the question. 87
Nephronophthisis-medullary cystic kidney disease complex: a report on 24 patients from 5 families with Italian ancestry. 87
Outcome of peritoneal dialysis: comparative studies. 86
Cyclosporin and renal injury. 86
Renal transplantation and peritoneal dialysis 85
Management of hypertension in chronic renal failure. 84
Chronic Ambulatory Peritoneal Dialysis 83
Predialysis versus postdialysis hematocrit evaluation during erythropoietin therapy. 83
32 cases of familial primary glomerulonephritis: HLA do not play a role in the genetic mechanism of the disease. 83
Prevention of peritonitis during CAPD: special precautions and use of connection systems. 82
Clinical and morphological features of kidney involvement in primary Sjogren's syndrome. 82
Kidney transplantation in peritoneal dialysis patients. 81
Reliability of clinical parameters for the selection of elderly cadaveric donors. 81
Trough cyclosporine concentration variability. 81
Ciclosporin in renal transplantation: identification of two populations with different drug metabolism. 80
Integration of peritoneal dialysis and transplantation programs. 78
Prospective controlled trial of a Y-Connector and disinfectant to prevent peritonitis in CAPD 76
Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study. 76
'Y' connector system for prevention of peritonitis in CAPD: a controlled study. 75
Behavior of plasma catecholamines in relation to pressure changes induced with hemodialysis or ultrafiltration 73
Access site-related infection in dialysis: the AStRID project: a multicenter prospective Italian study. 72
Steroid withdrawal six months after renal transplantation: comparison between azathioprine and cyclosporine versus cyclosporyne on monotherapy. A randomized monocenter trial. 72
Acquired haemolytic anemia (AHA) following ABO minor incompatibility: a rare example of graft versus host disease (GVHD) after renal transplantation (TX). 72
CAPD viability: a long-term comparison with hemodialysis 71
"Nocardiosi sistemica in corso di trapianto renale: quale strategia terapeutica ?". 71
Which treatment for which patients in the future? Possible modifications in CAPD 70
Is cyclosporine administration in twice daily dose in renal transplant advantageous? 70
Antibodies to HTLV III: epidemiological study in hemodialyzed, CAPD and transplanted patients. 70
Clinical evaluation of a peritoneal dialysis solution with 33 mmol/L bicarbonate. 69
Approccio fisiopatologico alla terapia della ipertensione arteriosa nella nefropatia diabetica. 69
32 casi di glomerulonefrite primitiva a carattere familiare: esiste un ruolo dell'HLA? 68
Are cyclosporine (Cs) deposits (DPS) in renal allografts of clinical significance? 68
Deposits of Cyclosporin in the renal allograft. 67
ABO-minor-incompatible kidney transplantation: not only O grafts can produce immune hemolysis. 65
Embolizzazione da cristalli di colesterolo (ECC): una causa crescente di insufficienza renale acuta. 64
The role of nephrogenous cGMP (NcGMP) as a mediator of PTH activity on renal tubules. A study of normal and nephropathic subjects with different reductions in glomerular filtrate 63
Sindrome di Alport associata a leiomiomatosi diffusa: una sindrome da geni contigui. 62
Evidence for the existence of a positive feedback of the degree of expansion of the circulating volume, atrial distension and atrial natriuretic peptide in dialyzed uremic patients 61
Hospitalization: CAPD versus hemodialysis and transplant. 61
Iperplasia gengivale indotta da ciclosporina (Cs): considerazioni cliniche e morfologiche. 61
Plasma porphyrins in patients treated with hemodialysis 60
"Fluconazole-resistant cryptococcal cellulitis in a kidney transplant patient". 60
Anticorpi anti HTLV III: studio epidemiologico in pazienti in dialisi e trapiantati renali. 60
Effetto renoprotettivo delle statine nei pazienti con malattia renale ateroembolica (MRA). 59
Glomerulonefrite IgA a carattere familiare; studio immunologico ed immunogenetico. 59
Utilità della scintigrafia con 99m Tc solfocolloidale nella diagnosi di rigetto nel rene trapiantato. 59
Long-term peritoneal dialysis outcome in a single center. 58
La plasmaferesi nel trattamento del rigetto acuto di allotrapianto di rene. Risultati di uno studio aperto e dati preliminari su uno studio controllato. 58
Cyclosporine-induced gingival hyperplasia: clinical and pathological findings. ? 58
Anticorpi anti- HCV e HCV- RNA nel siero, nei linfociti e nel criocrito di pazienti con CME e coinvolgimento renale. 58
Trombosi capillare glomerulare in assenza di immuno-depositi: inusuale coinvolgimento renale in paziente con LES ed anticorpi anticardiolipina. 57
Familial IgA Nephropaty: immunological and immunogenetical studies. 57
La funzione ormonale nel paziente in CAPD. 56
Inappropriate ADH secretion: an unusual manifestation of antiphospholipid syndrome? 56
Ricorrenza familiare di glomerulonefrite primitiva: esperienza di un singolo centro. 56
Cholesterol atheromatous embolism (CAE): an increasingly recognized cause of acute renal failure (ARF). 56
Sindrome iponatriemica da inappropriata secrezione di ADH (SIADH). Inusuale coinvolgimento cerebrale in paziente con LES e anticorpi anticardiolipina. 56
Thirty years of progress in peritoneal dialysis. 55
Is cyclosporine-induced chronic nephrotoxicity inevitable? 55
La glomerulonefrite da catene leggere: una rara manifestazione delle gammopatie monoclonali. Descrizione di due casi associati a gammopatia monoclonale benigna. 55
Type II Cryoglobulinemia with renal disease: HCV infection and follow up. 55
Kaposi (SK) complicating renal transplantation (TX): a report on 7 cases from a sigle centre. 55
Light chain nephropathy or light chain disease? 55
Immunogenetica della nefropatia a depositi mesangiali di IgA: confronto tra forme familiari e forme sporadiche. 55
Experiences with the Y-system 54
Assenza di effetti aritmogeni di alte dosi di steroide E.V. in pazienti con sindrome nefrosica. 54
E' evitabile la nefrotossicità acuta da Ciclosporina? 54
Totale 7.846
Categoria #
all - tutte 70.922
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.922


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.937 0 0 0 0 0 374 234 373 142 471 76 267
2020/20212.549 23 297 29 301 36 398 47 407 429 201 347 34
2021/20221.421 71 351 5 39 15 50 53 91 73 198 128 347
2022/20231.126 241 6 24 107 73 351 0 109 129 3 47 36
2023/20241.082 48 12 68 86 19 111 42 32 421 5 3 235
2024/20251.115 6 12 16 323 516 242 0 0 0 0 0 0
Totale 13.681